Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Feedback ( (GB:FDBK) ) is now available.
Feedback plc, the clinical infrastructure and digital health collaboration specialist, will publish its interim results for the half year ended 30 November 2025 on 17 February 2026 and will host a retail investor presentation and Q&A the same afternoon. The event is intended to brief existing and prospective shareholders on the company’s recent performance and future prospects, underlining Feedback’s effort to engage retail investors more actively as it seeks to scale its Bleepa® platform and capitalise on growth opportunities in UK and international healthcare markets.
The most recent analyst rating on (GB:FDBK) stock is a Hold with a £11.00 price target. To see the full list of analyst forecasts on Feedback stock, see the GB:FDBK Stock Forecast page.
Spark’s Take on GB:FDBK Stock
According to Spark, TipRanks’ AI Analyst, GB:FDBK is a Neutral.
The score is held down primarily by deteriorating financial performance (sharp revenue decline, very large/worsening losses, and ongoing cash burn), partially offset by a debt-free balance sheet. Technicals add modest support due to an upward trend, but extremely overbought signals raise near-term risk. Valuation provides limited support given negative earnings and no dividend yield data.
To see Spark’s full report on GB:FDBK stock, click here.
More about Feedback
Feedback plc is a UK-based clinical infrastructure specialist focused on unlocking productivity in health and care through digital connectivity and asynchronous collaboration. Its core product, the award-winning Bleepa® collaboration platform, connects digital infrastructure across healthcare systems to support secure information sharing, flexible working and more efficient, community-based care pathways. Operating a scalable software-as-a-service model, Feedback targets both domestic and international public and private healthcare markets, including the NHS, aiming to drive recurring revenue growth as its customer base expands.
Average Trading Volume: 113,905
Technical Sentiment Signal: Sell
Current Market Cap: £4.93M
For a thorough assessment of FDBK stock, go to TipRanks’ Stock Analysis page.